Cite
Katayama A, Wada J, Kataoka HU, et al. Two novel mutations of lecithin:cholesterol acyltransferase (LCAT) gene and the influence of APOE genotypes on clinical manifestations. NDT Plus. 2011;4(5):299-302doi: 10.1093/ndtplus/sfr091.
Katayama, A., Wada, J., Kataoka, H. U., Yamasaki, H., Teshigawara, S., Terami, T., Inoue, K., Kanzaki, M., Murakami, K., Nakatsuka, A., Sugiyama, H., Koide, N., Bujo, H., & Makino, H. (2011). Two novel mutations of lecithin:cholesterol acyltransferase (LCAT) gene and the influence of APOE genotypes on clinical manifestations. NDT plus, 4(5), 299-302. https://doi.org/10.1093/ndtplus/sfr091
Katayama, Akihiro, et al. "Two novel mutations of lecithin:cholesterol acyltransferase (LCAT) gene and the influence of APOE genotypes on clinical manifestations." NDT plus vol. 4,5 (2011): 299-302. doi: https://doi.org/10.1093/ndtplus/sfr091
Katayama A, Wada J, Kataoka HU, Yamasaki H, Teshigawara S, Terami T, Inoue K, Kanzaki M, Murakami K, Nakatsuka A, Sugiyama H, Koide N, Bujo H, Makino H. Two novel mutations of lecithin:cholesterol acyltransferase (LCAT) gene and the influence of APOE genotypes on clinical manifestations. NDT Plus. 2011 Oct;4(5):299-302. doi: 10.1093/ndtplus/sfr091. Epub 2011 Jul 26. PMID: 25984174; PMCID: PMC4421733.
Copy
Download .nbib